Both in Biotechnology
Kodiak Sciences vs CRISPR Therapeutics AG
Over the past year KOD returned +760.9% and CRSP returned −21.8%; their daily moves had a correlation of 0.21.
KOD +760.9% CRSP −21.8%Growth of $1, one year, split-adjusted
| Metric | KOD | CRSP |
|---|---|---|
| Price | $99.87 | $53.39 |
| Market cap | $6.28B | $5.16B |
| Today | +5.95% | +5.85% |
| 1 month | +203.8% | +2.2% |
| 6 months | +131.7% | +4.2% |
| Year to date | +257.2% | +1.8% |
| 1 year | +590.7% | −30.5% |
| Revenue growth (YoY) | — | +1041.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −895.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 385.5× |
| Net cash | $125.9M | $1.78B |
| Dividend yield | — | — |
| Volatility (60d) | 214.5% | 51.5% |
| Short % of float | 31.7% | 23.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).